US › Healthcare

Qilian International Holding Group Limited (BGM)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.30+4.19%

Last close · 2026-08-04

Latest quarter · ended 2025-09-30

Revenue

$23.6M

Net profit

$-19.1M

EPS

$-0.03

EPS estimate

$0.00

Net margin

-80.8%

Key statistics

Market cap

$116.6M

Forward P/E

0.0

P/B

0.29

Book value

$1.85

EPS (TTM)

$-0.18

52-week high

$11.80

52-week low

$0.25

50-day MA

$0.33

200-day MA

$2.82

Beta

1.46

Shareholding

Insiders

34.34%

Institutions

0.06%

Largest institutional holders

Fund	Stake
HRT FINANCIAL LLC	0.01%
Geode Capital Management, LLC	0.01%
State Street Corp	0.01%
TWO SIGMA SECURITIES, LLC	0.00%
Susquehanna International Group, LLP	0.00%
XTX Topco Ltd	0.00%
GSA Capital Partners LLP	0.00%
Tower Research Capital LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Qilian International Holding Group Limited — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.